arbekacin has been researched along with Respiratory Tract Infections in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Watanabe, A | 1 |
| Hara, K; Hayashi, T; Masuyama, Y; Oda, T; Saito, A; Shigeno, Y; Taira, K; Tomita, H; Yamaguchi, K | 1 |
1 trial(s) available for arbekacin and Respiratory Tract Infections
| Article | Year |
|---|---|
[Comparative clinical trial of HBK and amikacin (AMK) in the treatment of respiratory infections].
Topics: Adult; Aged; Aged, 80 and over; Amikacin; Aminoglycosides; Anti-Bacterial Agents; Bacterial Infections; Clinical Trials as Topic; Dibekacin; Double-Blind Method; Female; Humans; Kanamycin; Male; Middle Aged; Respiratory Tract Infections | 1987 |
1 other study(ies) available for arbekacin and Respiratory Tract Infections
| Article | Year |
|---|---|
[Respiratory tract infections in the elderly, advances and limitations in the diagnosis and treatment].
Topics: Aged; Aminoglycosides; Anti-Bacterial Agents; Cross Infection; Cytomegalovirus Infections; Dibekacin; Erythromycin; Humans; Methicillin Resistance; Pseudomonas aeruginosa; Pseudomonas Infections; Quinolones; Respiratory Tract Infections; Staphylococcal Infections; Vancomycin | 1992 |